Back to Search
Start Over
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
- Source :
-
Gastroenterology [Gastroenterology] 2011 Aug; Vol. 141 (2), pp. 476-85, 485.e1-11. Date of Electronic Publication: 2011 Apr 28. - Publication Year :
- 2011
-
Abstract
- Background & Aims: Gastric cancer (GC) is a heterogeneous disease comprising multiple subtypes that have distinct biological properties and effects in patients. We sought to identify new, intrinsic subtypes of GC by gene expression analysis of a large panel of GC cell lines. We tested if these subtypes might be associated with differences in patient survival times and responses to various standard-of-care cytotoxic drugs.<br />Methods: We analyzed gene expression profiles for 37 GC cell lines to identify intrinsic GC subtypes. These subtypes were validated in primary tumors from 521 patients in 4 independent cohorts, where the subtypes were determined by either expression profiling or subtype-specific immunohistochemical markers (LGALS4, CDH17). In vitro sensitivity to 3 chemotherapy drugs (5-fluorouracil, cisplatin, oxaliplatin) was also assessed.<br />Results: Unsupervised cell line analysis identified 2 major intrinsic genomic subtypes (G-INT and G-DIF) that had distinct patterns of gene expression. The intrinsic subtypes, but not subtypes based on Lauren's histopathologic classification, were prognostic of survival, based on univariate and multivariate analysis in multiple patient cohorts. The G-INT cell lines were significantly more sensitive to 5-fluorouracil and oxaliplatin, but more resistant to cisplatin, than the G-DIF cell lines. In patients, intrinsic subtypes were associated with survival time following adjuvant, 5-fluorouracil-based therapy.<br />Conclusions: Intrinsic subtypes of GC, based on distinct patterns of expression, are associated with patient survival and response to chemotherapy. Classification of GC based on intrinsic subtypes might be used to determine prognosis and customize therapy.<br /> (Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Aged, 80 and over
Cisplatin therapeutic use
Female
Fluorouracil therapeutic use
Humans
Kaplan-Meier Estimate
Male
Microarray Analysis
Middle Aged
Organoplatinum Compounds therapeutic use
Oxaliplatin
Prognosis
Proportional Hazards Models
Stomach Neoplasms drug therapy
Stomach Neoplasms pathology
Survival Rate
Young Adult
Biomarkers, Tumor metabolism
Cadherins metabolism
Galectin 4 metabolism
Gene Expression Profiling
Stomach Neoplasms classification
Stomach Neoplasms genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0012
- Volume :
- 141
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- 21684283
- Full Text :
- https://doi.org/10.1053/j.gastro.2011.04.042